BioSpace News Archive

As children return to school this fall, one in five youth will have obesity. To help combat this disease and promote a healthier lifestyle, The Obesity Society (TOS) will host a variety of activities recognizing National Childhood Obesity Awareness Month in September.

Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of K2M Group Holdings, Inc.

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced the appointment of Stanley Iyadurai, M.D., Ph.D. as Vice President of Clinical Development.

Personalis., a leading provider of advanced genomic sequencing and analytics to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies, today announced that they are scheduled to present at the Immuno-Oncology Summit in Boston, MA on August 30, 2018 at 12:15 PM ET.

Allegheny Health Network today announced the closing of $1B in bond financing, its first ever public tax-exempt financing.

A spin-out company from the renowned Korea Advanced Institute of Science and Technology in Daejeon has been established to commercialize the revolutionary Holotomography (HT) microscopy developed there by Professor YongKeun (Paul) Park.

The Institute for Bioscience and Biotechnology Research (IBBR) has entered into two separate collaborations involving its polyphosphazene (PPZ) polymer platform.

Altasciences announced today that construction work has begun on the expansion of their ligand binding laboratory to meet the high demand for quality bioanalytical services. The additional space will include a fully-equipped, state-of-the-art lab dedicated to ligand binding and cell based assays.

Adocia, the biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of approved proteins, announced today that the Arbitration Panel presiding over Adocia’s arbitration claims against Eli Lilly & Company (“Lilly”) has found in favor of Adocia on the first of the claims to be resolved.

The global medical walkers market 2018-2022 is expected to post a CAGR of around 5% during the forecast period, according to the latest market research report by Technavio.